Guides et références
Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule
In February 2015, a nine-valent human papillomavirus vaccine (HPV9) was authorized for use in Canada. The purpose of this statement is to summarize information on this vaccine and to provide evidence-based recommendations on its use in the context of recommendations for all HPV vaccines currently authorized for use in Canada. In addition, this statement will clarify minimum intervals between doses of HPV vaccines for two-dose and three-dose HPV immunization schedules.
Updated recommendations for the use of varicella zoster immune globulin (VarIg) for the prevention of varicella in at-risk patients: An Advisory Committee Statement (ACS)
Highlights key information for immunization providers. VarIg is recommended for individuals who are at increased risk of severe varicella if significant exposure has occurred. These individuals include: susceptible pregnant women; newborn infants of mothers who develop varicella from 5 days before until 48 hours after delivery; selected neonates in neonatal or pediatric intensive-care settings; susceptible immunocompromised individuals, including susceptible HIV-infected persons and hematopoietic stem cell transplantation recipients.
Utilisation du VVAI chez les enfants et les adolescents - Addenda à la Déclaration du Comité consultatif national de l'immunisation (CCNI)
Cet addenda au Chapitre sur la grippe du Guide canadien d'immunisation et à la Déclaration sur la vaccination antigrippale pour la saison 2016-2017 comprend les nouvelles recommandations concernant l'utilisation du vaccin antigrippal vivant atténué chez les enfants âgés de 2 à 17 ans.
Varicella Proof of Immunity - 2015 Update: An Advisory Committee Statement (ACS)
The National Advisory Committee on Immunization (NACI) currently recommends a 2-dose varicella vaccination schedule for all children aged 12 months to 12 years of age. Susceptible adolescents (12 to 17 years) and adults (18 years and older) should also be vaccinated. The Canadian Immunization Guideenumerates criteria for proof of immunity.
When parents choose not to vaccinate: risks and responsibilities
This resource was adapted from If You Choose Not to Vaccinate Your Child, Understand the Risks and Responsibilities (World Health Organization Regional Office for Europe) and reviewed by the Canadian Paediatric Society's Infectious Diseases and Immunization Committee. It is a helpful Canadian version that healthcare providers can share with parents and caregivers.
Adult immunization: Communicating with patients
Immunizations are recommended through all stages of life, and are significant to promoting good health. Health care providers can help patients identify which vaccines they need to stay healthy. These slides, offered by Immunize Canada, are designed to assist health care providers when communicating with their adult patients.
An Advisory Committee Statement: Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule
This statement provides an overview of previous NACI recommendations for HPV immunization; outlines the national goal for HPV immunization, and current status of HPV immunization programs in Canada; summarizes the evidence reviewed and evidence-based recommendations made by other immunization technical advisory groups that informed the development of this statement; and provides recommendations for the optimal HPV immunization schedule in Canada.
Déclaration du comité consultatif : Mise à jour des recommandations visant le calendrier d'immunisation relatif au vaccin contre le virus du papillome humain (VPH)
La présente déclaration fournit un aperçu des recommandations précédentes du Comité consultatif national de l’immunisation (CCNI) pour l’immunisation contre le VPH; présente l’objectif national en matière d’immunisation contre le VPH et la situation actuelle des programmes d’immunisation contre le VPH au Canada; résume les données probantes examinées et les recommandations basées sur ces données faites par d’autres groupes consultatifs techniques sur l’immunisation qui ont permis d’élaborer la présente déclaration; et fournit des recommandations relatives au calendrier optimal d’immunisation contre le VPH au Canada.
Immunization as a tool to combat antimicrobial resistance
Vaccines and immunization programs can play a key role in addressing the growing challenge of antimicrobial resistance (AMR). Not only do vaccines prevent infections, they can also prevent secondary opportunistic infections from AMR microbes, for example, bacterial pneumonia following influenza infections. The reduced need to treat these opportunistic infections would also mitigate the advance of AMR microbes in our communities.
Improving Adult Immunization: Information for health care providers
Under-immunization for vaccine-preventable diseases is common among Canadian adults. While immunizations are recommended through all stages of life, it is the responsibility of health care providers to inform patients about the vaccines they need to stay healthy and prevent infection. These slides offered by Immunize Canada are designed to assist health care providers to increase their knowledge on adult immunization. The information in this resource is based on recommendations from the National Advisory Committee on Immunization (NACI) and the Canadian Immunization Guide (CIG).